Charles River Laboratories is boosting its capacity to understand how the immune cell compartment works within the tumor microenvironment under a new deal with Cypre Inc. The nonclinical CRO will work ...
Collaboration will provide access to Falcon-X™ 3D Tumor Model Platform The Falcon-X™ 3D In Vitro Tumor Assay Platform is a high content analysis screening option for cancer immunotherapy and targeted ...
Charles River Laboratories International, Inc. CRL entered into an agreement with German biotech company, CELLphenomics. Through the partnership, Charles River clients will have access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results